PATENT CLAIM ANALYSIS

Application Number: 15763777
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["424", "400000"]

Abstract:
The disclosure provides methods for treating psychiatric diseases, such as schizophrenia, in patients with certain gene polymorphisms using antipsychotic drugs, such as risperidone and paliperidone.

Claim (Index 18):
The method of  claim 15  or  16 , wherein the MC4R gene polymorphism is an rs17782313 single nucleotide polymorphism; wherein the HTR2C gene polymorphism is an rs3813929 single nucleotide polymorphism; and wherein the HTR2A gene polymorphism is an rs6313 single nucleotide polymorphism.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 1.16
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15122101', '12675598', '15085778', '14506253', '15116786']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7619165322600591
- 35 USC 102 Novelty (BERT): 0.5429335630581251
- Combined Prediction Score: 0.7400182353398658
- Mean Citation Score: 327.979276
- Max Citation Score: 400.5682
- Similarity Product: 273.00874739568235

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test